88IV - PR Newswire Asia's news


WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence SINGAPORE , Aug. 18, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused ... 2026-08-18T Biotechnology Medical/Pharmaceuticals
Biosolutions could help Japan become a global bioeconomy powerhouse, new report finds A new report, The Value of Biosolutions: Growth and Prosperity to 2035 – Japan Edition , highlights how biosolutions could strengthen Japan's position as a global biomanufacturing hub and ... 2026-08-18T Agriculture Biotechnology Chemical Environmental Products & Services
Enginprime Medical Closes $12M Series A Financing Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development ... 2026-08-18T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths CAMBRIDGE, Mass. , Aug. 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI) , announced ... 2026-08-17T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors — ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) — ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Announces 2026 Interim Results CHENGDU, China , Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (" Kelun-Biotech " or the " Company ", Stock Code: 6990.HK ) announces its ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
New Study Confirms Capsugel® Enprotect® Capsules Deliver Robust Gastric Integrity Under Both Fasted and Fed Conditions SEOUL, South Korea , Aug. 14, 2026 /PRNewswire/ -- Enteric capsules are widely used to protect acid-sensitive compounds and to delay drug release until intestinal entry. However, evidence supporting ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics NANJING, China and SINGAPORE , Aug. 14, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio) today announced the completion of its acquisition of MediSix Therapeutics ("MediSix"), a Singapore-based ... 2026-08-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate Phase 1b study will evaluate safety and pharmacokinetics of RSM01 in approximately 80 infants aged 2 weeks to 8 months Company expands its global portfolio beyond vaccines into antibody-based preventive ... 2026-08-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology